☆ 4.6 Editorial Material

Biomarkers in acute lung injury: Are we making progress?

CRITICAL CARE MEDICINE (2008)

Journal

CRITICAL CARE MEDICINE

Volume 36, Issue 8, Pages 2457-2459

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/CCM.0b013e318181052a

Keywords

acute lung injury; acute respiratory distress syndrome; biomarker; prognostic

Categories

Critical Care Medicine

Funding

NCATS NIH HHS [UL1 TR000454] Funding Source: Medline
NCRR NIH HHS [UL1 RR025008, UL1 RR025008-01] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Biochemistry & Molecular Biology

MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome

Qianying Lu, Sifan Yu, Xiangyan Meng, Mingyu Shi, Siyu Huang, Junfeng Li, Jianfeng Zhang, Yangfan Liang, Mengjun Ji, Yanmei Zhao, Haojun Fan

Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is an inflammatory response that destroys lung parenchymal cells and reduces lung function. MicroRNAs play a crucial role in regulating inflammatory and immune responses in ALI/ARDS and may serve as diagnostic indicators and therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Critical Care Medicine

Prognostic Value of Angiopoietin-like 4 in Patients with Acute Respiratory Distress Syndrome

Jun Hu, Lian Liu, Xianghu Zeng, Ke Wang, Hao Wang, Zijian Zeng, Yufang Cao, Lijuan Gao, Mengxin Cheng, Tao Wang, Fuqiang Wen

Summary: The study revealed that ANGPTL4 levels were elevated in patients with ARDS and significantly correlated with disease severity and mortality, suggesting that ANGPTL4 may serve as a novel prognostic biomarker in ARDS.

SHOCK (2021)

Add to Collection

Review Nanoscience & Nanotechnology

Nanomedicine-Based Therapeutics to Combat Acute Lung Injury

Shuai Bian, Hongfei Cai, Youbin Cui, Wanguo Liu, Chunsheng Xiao

Summary: ALI and ARDS can cause life-threatening respiratory failure with a high mortality rate. Despite some clinical interventions, there is still no completely effective treatment for ALI. Recent advances in nanotechnology may provide new possibilities for the pharmacotherapy of ALI.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Add to Collection

Article Immunology

A bibliometric analysis of NLRP3 inflammasome in acute lung injury/acute respiratory distress syndrome from 2010 to 2021

Zhuoran Xiao, Song Hu, Wenting Xu, Sheng Wang, Wei Mo, Huimin Deng, Juan Wei, Hao Yang, Wenyu Zhou, Quanfu Li, Huanping Zhou, Xin Lv

Summary: This bibliometric analysis reveals a rapid growth trend of NLRP3 inflammasome in ALI/ARDS. China is the largest contributor, while the USA offers the most landmark papers. The major disciplines of research front have shifted from Medicine, Medical, Clinical to Molecular, Biology, Immunology. In recent years, studies on the role of NLRP3 in COVID-19-associated ALI/ARDS and oxidative stress have become hotspots.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis

Laetitia Pouzol, Anna Sassi, Nadege Baumlin, Melanie Tunis, Daniel S. Strasser, Francois Lehembre, Marianne M. Martinic

Summary: The loss of control in immune cell trafficking to inflamed lung tissue leads to ALI/ARDS. The paper investigates the pathological role of the CXCR3/CXCR4/CXCR7 axis in a murine model of ALI. The study suggests the clinical potential of the CXCR7 antagonist, ACT-1004-1239, in reducing inflammation and improving lung function in ALI/ARDS.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Cell Biology

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

Chang Liu, Kun Xiao, Lixin Xie

Summary: This review discusses the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and the biological characteristics and mechanisms of mesenchymal stromal cells (MSCs) in the treatment of ALI/ARDS.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Molecular markers of type II alveolar epithelial cells in acute lung injury by bioinformatics analysis

Xiaoting Yang, Jing Wang, Wei Liu

Summary: In this study, molecular markers associated with type II alveolar epithelial cell injury in acute lung injury (ALI) were identified using bioinformatics methods. The results provide new insights for the diagnosis and treatment of ALI/ARDS.

SCIENTIFIC REPORTS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Circulating Pulmonary-Originated Epithelial Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis

Huishu Lin, Qisijing Liu, Lei Zhao, Ziquan Liu, Huanhuan Cui, Penghui Li, Haojun Fan, Liqiong Guo

Summary: This systematic review and meta-analysis identified KL-6, CC16, and SP-D as ideal biomarkers for accurately reflecting the pathophysiological characteristics of ARDS, identifying at-risk patients, and predicting mortality.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Plant Sciences

Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo

JunMei Wang, Chunxiu Ren, WenHui Bi, Wuliji Batu

Summary: Glycyrrhiza glabra L. is a widely used traditional Chinese medicine with various therapeutic effects. This study found that its active ingredient, glycyrrhizin, has anti-inflammatory effects and can alleviate acute lung injury (ALI) by interfering with the NF-κB/NLRP3 signaling pathway.

JOURNAL OF ETHNOPHARMACOLOGY (2023)

Add to Collection

Review Pharmacology & Pharmacy

Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms

Yu-Qiong He, Can-Can Zhou, Lu-Yao Yu, Liang Wang, Jiu-Ling Deng, Yu-Long Tao, Feng Zhang, Wan-Sheng Chen

Summary: ALI and ARDS are common life-threatening lung diseases with high mortality rates, but there is still a lack of effective pharmacological therapies. Developing new drugs for therapy of ALI/ARDS is in great demand, as natural compounds have shown potential therapeutic effects and may also be helpful for treatment of COVID-19.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

NLRP3 inflammasome activation in cigarette smoke priming for Pseudomonas aeruginosa-induced acute lung injury

Alexis White, Zhengke Wang, Xing Wang, Michelle King, Cynthia Guo, Chris Mantsounga, Alfred Ayala, Alan R. Morrison, Gaurav Choudhary, Frank Sellke, Eboni Chambers, Lorraine B. Ware, Sharon Rounds, Qing Lu

Summary: Cigarette smoke exposure increases the incidence and severity of acute respiratory distress syndrome (ARDS), but the mechanisms are unclear. This study found that cigarette smoke impairs mitophagy flux and exacerbates mitochondrial damage and NLRP3 inflammasome activation, leading to increased acute lung injury. Inhibition of inflammasome or downstream component IL-1 beta attenuates the cigarette smoke-induced lung injury.

REDOX BIOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome

Chuanyu Zhuang, Minji Kang, Minhyung Lee

Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung disease, mainly caused by sepsis, infections, trauma, toxic reagents, and COVID-19. Current treatment options for ALI/ARDS are limited, but gene therapy using therapeutic nucleic acids has shown potential. Two classes of therapeutic nucleic acids, knock-in genes and oligonucleotides, have been developed for the treatment of ALI/ARDS. Delivery systems for efficient delivery of therapeutic nucleic acids into the lungs have also been explored. This review discusses ALI/ARDS gene therapy mainly in terms of delivery systems and provides insights for the development of new treatment strategies.

JOURNAL OF CONTROLLED RELEASE (2023)

Add to Collection

Article Medicine, Research & Experimental

Lumican is elevated in the lung in human and experimental acute respiratory distress syndrome and promotes early fibrotic responses to lung injury

Ke Wang, Youyu Wang, Yufang Cao, Hao Wang, Yongfang Zhou, Lijuan Gao, Zijian Zeng, Mengxin Cheng, Xiaodong Jin, Jun Chen, Fuqiang Wen, Tao Wang

Summary: This study found that lumican is increased in the early phase of acute respiratory distress syndrome (ARDS), and is associated with disease severity and inflammatory fibrotic processes. Lumican promotes fibrotic responses in ARDS by triggering the transdifferentiation of lung fibroblasts into myofibroblasts and epithelial-mesenchymal transition.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Immunology

The role of immunometabolism in macrophage polarization and its impact on acute lung injury/acute respiratory distress syndrome

Lian Wang, Dongguang Wang, Tianli Zhang, Yao Ma, Xiang Tong, Hong Fan

Summary: Lung macrophages play a crucial role in defending against airborne particles and microbes. They are also involved in the development of acute lung injury and acute respiratory distress syndrome by modulating inflammatory responses and repairing damaged lung tissues. Macrophage polarization, which is regulated by immunometabolism and its intermediates, may provide new therapeutic targets for ALI/ARDS.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Engineering, Environmental

Specific upregulation of extracellular miR-6238 in particulate matter-induced acute lung injury and its immunomodulation

Sujeong Park, Miji Kim, Minkyung Park, Yang Jin, Seon-Jin Lee, Heedoo Lee

Summary: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe inflammatory diseases characterized by the destruction of lung tissue and the upregulation of specific miRNAs, such as miR-6238. This study found that miR-6238 is specifically upregulated in response to particulate matter (PM) exposure but not bacterial endotoxin (LPS/PTG), and it plays a role in regulating inflammatory responses in alveolar macrophages (AMs). These findings suggest that miR-6238 could serve as a biomarker to distinguish PM-induced ALI from endotoxin-mediated ALI.

JOURNAL OF HAZARDOUS MATERIALS (2023)

Add to Collection

Editorial Material Hematology

Covid-19 will not magically disappear: Why access to widespread testing is paramount

Paul E. George, Claire L. Stokes, Leda C. Bassit, Ann Chahroudi, Janet Figueroa, Mark A. Griffiths, Stacy Heilman, David N. Ku, Eric J. Nehl, Traci Leong, Joshua M. Levy, Russell R. Kempker, Robert G. Mannino, Maud Mavigner, Sunita I. Park, Anuradha Rao, Paulina A. Rebolledo, John D. Roback, Beverly B. Rogers, Raymond F. Schinazi, Allie B. Suessmith, Julie Sullivan, Erika A. Tyburski, Miriam B. Vos, Jesse J. Waggoner, Yun F. (Wayne) Wang, Jen Madsen, Daniel S. Wechsler, Clinton H. Joiner, Greg S. Martin, Wilbur A. Lam

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry

Juan Pablo Domecq, Amos Lal, Christopher R. Sheldrick, Vishakha K. Kumar, Karen Boman, Scott Bolesta, Vikas Bansal, Michael O. Harhay, Michael A. Garcia, Margit Kaufman, Valerie Danesh, Sreekanth Cheruku, Valerie M. Banner-Goodspeed, Harry L. Anderson, Patrick S. Milligan, Joshua L. Denson, Catherine A. St Hill, Kenneth W. Dodd, Greg S. Martin, Ognjen Gajic, Allan J. Walkey, Rahul Kashyap

Summary: This study aimed to describe the outcomes of hospitalized patients with COVID-19 in a multicenter, international registry. Age and type of organ support therapies were found to affect the prognosis of patients, with significant variations in hospital mortality and discharge rates among different groups receiving organ support therapies. Interhospital variation in mortality of mechanically ventilated patients was not solely attributed to patient characteristics, suggesting the need for further evaluation.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update

Waleed Alhazzani, Laura Evans, Fayez Alshamsi, Morten Hylander Moller, Marlies Ostermann, Hallie C. Prescott, Yaseen M. Arabi, Mark Loeb, Michelle Ng Gong, Eddy Fan, Simon Oczkowski, Mitchell M. Levy, Lennie Derde, Amy Dzierba, Bin Du, Flavia Machado, Hannah Wunsch, Mark Crowther, Maurizio Cecconi, Younsuck Koh, Lisa Burry, Daniel S. Chertow, Wojciech Szczeklik, Emilie Belley-Cote, Massimiliano Greco, Malgorzata Bala, Ryan Zarychanski, Jozef Kesecioglu, Allison McGeer, Leonard Mermel, Manoj J. Mammen, Sheila Nainan Myatra, Amy Arrington, Ruth Kleinpell, Giuseppe Citerio, Kimberley Lewis, Elizabeth Bridges, Ziad A. Memish, Naomi Hammond, Frederick G. Hayden, Muhammed Alshahrani, Zainab Al Duhailib, Greg S. Martin, Lewis J. Kaplan, Craig M. Coopersmith, Massimo Antonelli, Andrew Rhodes

Summary: The Surviving Sepsis Campaign Coronavirus Disease 2019 panel issued nine statements on managing severe or critical coronavirus disease 2019 in the ICU, including recommendations for systemic corticosteroids and venous thromboprophylaxis while strongly advising against the use of hydroxychloroquine. The panel also made suggestions for the use of dexamethasone, remdesivir, convalescent plasma, and therapeutic anticoagulation, based on the available evidence.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

Georgia M. Davis, Eileen Faulds, Tara Walker, Debbie Vigliotti, Marina Rabinovich, Joi Hester, Limin Peng, Barbara McLean, Patricia Hannon, Norma Poindexter, Petrena Saunders, Citlalli Perez-Guzman, Seema S. Tekwani, Greg S. Martin, Guillermo Umpierrez, Shivani Agarwal, Kathleen Dungan, Francisco J. Pasquel

Summary: The study shows that a hybrid protocol integrating CGM and POC is helpful for managing critically ill patients with COVID-19 requiring insulin infusion. Sensor accuracy is impacted by mechanical interferences, but the majority of sensor values are within 20% of reference POC glucose levels.

DIABETES CARE (2021)

Add to Collection

Editorial Material Pathology

Future potential of Rapid Acceleration of Diagnostics (RADx Tech) in molecular diagnostics

Steven C. Schachter, Denise R. Dunlap, Wilbur A. Lam, Yukari C. Manabe, Greg S. Martin, Sally M. McFall

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Add to Collection

Article Critical Care Medicine

Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges

Sara C. Auld, Kristin R. Harrington, Max W. Adelman, Chad J. Robichaux, Elizabeth C. Overton, Mark Caridi-Scheible, Craig M. Coopersmith, David J. Murphy

Summary: This study aims to explore the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. The study found that the risk of death was highest for patients admitted during the fall and winter of 2020. Hospital mortality was associated with preexisting risk factors, clinical status at ICU admission, and ICU interventions.

CRITICAL CARE MEDICINE (2022)

Add to Collection

Letter Biotechnology & Applied Microbiology

The need for new test verification and regulatory support for innovative diagnostics

John D. Roback, Erika A. Tyburski, David Alter, Saja Asakrah, Ann Chahroudi, Annette Esper, Sarah Farmer, Janet Figueroa, Jennifer K. Frediani, Mark D. Gonzalez, David S. Gottfried, Jeannette Guarner, Nitika A. Gupta, Stacy S. Heilman, Charles E. Hill, Robert Jerris, Russell R. Kempker, Jessica Ingersoll, Joshua M. Levy, Maud Mavigner, Carlos S. Moreno, Claudia R. Morris, Eric J. Nehl, Andrew S. Neish, Deniz Peker, Natia Saakadze, Paulina A. Rebolledo, Christina A. Rostad, Nils Schoof, Allie Suessmith, Julie Sullivan, Yun F. (Wayne) Wang, Anna Wood, Miriam B. Vos, Oliver Brand, Greg S. Martin, Wilbur A. Lam

NATURE BIOTECHNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

A scalable workflow to characterize the human exposome

Xin Hu, Douglas Walker, Yongliang Liang, Matthew Ryan Smith, Michael L. Orr, Brian D. Juran, Chunyu Ma, Karan Uppal, Michael Koval, Greg S. Martin, David C. Neujahr, Carmen J. Marsit, Young-Mi Go, Kurt D. Pennell, Gary W. Miller, Konstantinos N. Lazaridis, Dean P. Jones

Summary: The authors have developed a workflow for mass spectrometry-based untargeted exposome profiling of both known and unknown environmental chemicals. The method addresses the challenge of complementing the genome with an understanding of the human exposome and overcomes limitations in targeted environmental chemical analysis. This approach allows for quantification of environmental chemicals in human samples with high resolution and sensitivity, without the need for prior knowledge of chemical identity.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration

Jennifer K. Frediani, Joshua M. Levy, Anuradha Rao, Leda Bassit, Janet Figueroa, Miriam B. Vos, Anna Wood, Robert Jerris, Van Leung-Pineda, Mark D. Gonzalez, Beverly B. Rogers, Maud Mavigner, Raymond F. Schinazi, Nils Schoof, Jesse J. Waggoner, Russell R. Kempker, Paulina A. Rebolledo, Jared W. O'Neal, Cheryl Stone, Ann Chahroudi, Claudia R. Morris, Allie Suessmith, Julie Sullivan, Sarah Farmer, Amanda Foster, John D. Roback, Thanuja Ramachandra, CaDeidre Washington, Kristie Le, Maria C. Cordero, Annette Esper, Eric J. Nehl, Yun F. Wang, Erika A. Tyburski, Greg S. Martin, Wilbur A. Lam

Summary: Though there has been progress in rapid COVID-19 testing technology, challenges remain in accurately detecting viral variants and implementing self-testing at home. Research indicates that BinaxNOW can detect various new variants, but sensitivity may decrease due to user error.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Multidisciplinary Sciences

Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2

Joshua M. Levy, Jennifer K. Frediani, Erika A. Tyburski, Anna Wood, Janet Figueroa, Russell R. Kempker, Paulina A. Rebolledo, Mark D. Gonzalez, Julie Sullivan, Miriam B. Vos, Jared O'Neal, Greg S. Martin, Wilbur A. Lam, Jesse J. Waggoner

Summary: The impact of repeated sample collection on COVID-19 test performance is unknown. The study found high concordance between consecutively collected mid-turbinate samples with both molecular and antigen-based diagnostic assays. This demonstrates that repeated sample collection does not decrease COVID-19 test performance, allowing for multiple samples to be collected for assay validation and clinical diagnosis.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Nutrition & Dietetics

Biological Effects of Intravenous Vitamin C on Neutrophil Extracellular Traps and the Endothelial Glycocalyx in Patients with Sepsis-Induced ARDS

Xian Qiao, Markos G. Kashiouris, Michael L'Heureux, Bernard J. Fisher, Stefan W. Leichtle, Jonathon D. Truwit, Rahul Nanchal, Robert Duncan Hite, Peter E. Morris, Greg S. Martin, Jonathan Sevransky, Alpha A. Fowler

Summary: In this study, the disease-modifying effects of high-dose intravenous vitamin C (HDIVC) on sepsis-induced acute respiratory distress syndrome (ARDS) were investigated. It was found that HDIVC infusion could attenuate cell-free DNA and syndecan-1 levels, which are biomarkers associated with sepsis-induced ARDS.

NUTRIENTS (2022)

Add to Collection

Article Environmental Sciences

Lessons Learned from In-Person Conferences in the Times of COVID-19

Maryam Ehteshami, Carlos Leon Edgar, Lucia Yunuen Delgado Ayala, Michael Hagan, Greg S. Martin, Wilbur Lam, Raymond F. Schinazi

Summary: Scientific societies and conference secretariats have resumed in-person meetings with COVID-19 safety measures in place. The MEX-DART case study conducted at the Hep-DART 2021 conference highlighted the successful implementation of safety measures, including vaccination requirements, social distancing, mask wearing, and daily rapid testing. None of the 166 delegates tested positive during the conference, but two delegates tested positive after the conference, suggesting they contracted the virus during their travels or postconference vacation. This case study serves as a helpful template for organizing future in-person meetings, but caution is still necessary due to seasonal surges in respiratory virus infections.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Clinical Outcomes of Critically III Patients with COVID-19 by Race

Fahad Marmarchi, Michael Liu, Srikant Rangaraju, Sara C. Auld, Maria Christina Creel-Bulos, Christine L. Kempton, Milad Sharifpour, Manila Gaddh, Roman Sniecinski, Cheryl L. Maier, Fadi Nahab

Summary: The study found that African Americans admitted to the ICU with COVID-19 had higher rates of comorbidities, such as hypertension and diabetes, but showed no significant difference in mortality compared to other races.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2022)

Add to Collection

Correction Critical Care Medicine

Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry (vol 49, pg 437, 2021)

Juan Pablo Domecq, Amos Lal, Christopher R. Sheldrick, Vishakha K. Kumar, Karen Boman, Scott Bolesta, Vikas Bansal, Michael O. Harhay, Michael A. Garcia, Margit Kaufman, Valerie Danesh, Sreekanth Cheruku, Valerie M. Banner-Goodspeed, Harry L. Anderson, Patrick S. Milligan, Joshua L. Denson, Catherine A. St Hill, Kenneth W. Dodd, Greg S. Martin, Ognjen Gajic, Allan J. Walkey, Rahul Kashyap

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

COVID-19: What we've done well and what we could or should have done better-the 4 Ps

Jean-Louis Vincent, Julia Wendon, Greg S. Martin, Nicole P. Juffermans, Jacques Creteur, Maurizio Cecconi

Summary: The current coronavirus pandemic has heavily impacted ICUs worldwide, putting immense pressure on healthcare systems and staff. It is important to learn from both the positive and negative aspects of the response to improve organization and patient care in the future.

CRITICAL CARE (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.